QRay
Home-based Phototherapeutic Devices for Chronic Wounds
Company Overview
Snapshot
Founded in December 2005, QRay operates with 1–10 employees. The company is focused on developing phototherapeutic devices and in September 2006, initiated a skin treatment trial.
Business overview
QRay develops and manufactures patient-administered phototherapeutic devices designed for the treatment of chronic wounds and oral ulcers, as well as for the alleviation of chronic pain conditions. The company's core technology, Visible Light Therapy (VLT), utilizes the full spectrum of visible light bandwidths to offer a non-invasive, chemical-free approach to healing various disorders. QRay's flagship product, Vireo, is a fully adjustable, patient-friendly phototherapy device based on VLT technology, which has demonstrated clinical efficacy in healing and closing chronic wounds. The company serves the healthcare and life sciences sectors, targeting medical device industries, healthcare providers, and patients with its home-care medical products.
Strategic signal
In September 2006, QRay commenced a skin treatment trial, indicating early-stage validation and development of its phototherapeutic devices. This signals the company's commitment to clinical testing and advancing its Visible Light Therapy (VLT) technology for practical medical applications.
Log in to access full profile ›Company Intelligence Q&A
- What is QRay's primary focus?
- QRay develops and manufactures home-based phototherapeutic devices for the treatment of chronic wounds and oral ulcers, and for alleviating chronic pain conditions.
- What is the company's core technology?
- QRay's core technology is Visible Light Therapy (VLT), which harnesses the full spectrum of visible light bandwidths for non-invasive treatment.
- When was QRay founded?
- QRay was founded in December 2005.
- What is QRay's flagship product?
- QRay's flagship product is Vireo, a fully adjustable, patient-friendly phototherapy device based on VLT technology designed for healing chronic wounds.
- What significant development occurred in September 2006?
- In September 2006, QRay began a skin treatment trial for its phototherapeutic devices.